Slides on Lessons Learned From Lockdown: Viral Hepatitis–Related Liver Disease in the COVID-19 Era

Key slides on COVID-19 and viral hepatitis–related chronic liver disease (CLD), including COVID-19 outcomes in patients with CLD and expert guidance on clinical management, vaccination, and optimization of telemedicine for patients with CLD during the COVID-19 pandemic.
Format: Microsoft PowerPoint (.ppt)
File Size: 483 KB
Released: January 10, 2022

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grants provided by:
AbbVie
Gilead Sciences, Inc.

Related Content

Patient perspectives and key action items to address in clinical settings to reduce HBV care barriers in the United States, from Clinical Care Options (CCO)

Maria Buti, MD person default Silvana Lesidrenska Released: October 5, 2022

Patient perspectives and key action items to address in clinical settings to reduce HBV care barriers in China, from Clinical Care Options (CCO)

person default Dee Lee person default Jie Li, MD, PhD Released: October 4, 2022

Perspectives and key action items to address in clinical settings to reduce HBV care barriers in Japan, from Clinical Care Options (CCO)

person default Hidenori Toyoda, MD, PhD, FACP Released: October 4, 2022

Grace Wong, MD: use of an interactive decision support tool to guide screening for and treatment of HDV, from Clinical Care Options (CCO)

Grace LH Wong, MD Released: September 12, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings